High Risk Rheumatic and Musculoskeletal and Skin Diseases Research

The summary for the High Risk Rheumatic and Musculoskeletal and Skin Diseases Research grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

High Risk Rheumatic and Musculoskeletal and Skin Diseases Research: The purpose of this initiative is to broaden the base of inquiry in fundamental biomedical, biobehavioral, and biomedical technology research by encouraging applications for research projects that involve an especially high degree of innovation and novelty and, therefore, require a preliminary test of feasibility. The goal is to solicit research applications with the potential for developing groundbreaking technology or methodology that may lead to significant expansion of biomedical research horizons, precipitate a paradigm shift in research, or lead to substantial improvements in human health. Research projects proposed under this Request for Applications (RFA) may involve substantial experimental risks such that their potential for highly significant outcomes may be difficult to judge by the standard criteria used in evaluating investigator initiated (R01) proposals. Preliminary data are not required. The work proposed may not overlap with the aims of currently supported projects or those in which the Principal Investigator has participated during the past five years. Proposed projects must support the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Two kinds of experienced and established investigators are sought. First, experienced and established investigators in rheumatic or musculoskeletal or skin diseases are encouraged to present a proposal for testing the feasibility of a novel idea, resource or technology. The project should represent a clear and distinctly different approach from the investigator's current and previous (past 5 years) research. Second, experienced and established investigators with no previous work in rheumatic or musculoskeletal or skin diseases are encouraged to apply their expertise to research that is relevant to rheumatic or musculoskeletal or skin diseases. This request for applications should not be considered for new investigators without previous grant experience.